

| Catalog No. | CF977016 | ||||
|---|---|---|---|---|---|
| Description |
Cirevetmab (CF977016) is a research-grade recombinant antibody targeting TGFB1/TGF-beta-1. Produced in mammalian cells with native-like glycosylation.
Highlights
|
||||
| Species reactivity | Canine | ||||
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | ||||
| Host species | Canine | ||||
| Isotype | IgG2, kappa | ||||
| Expression system | Mammalian cells | ||||
| Clonality | Monoclonal | ||||
| Target | TGFB1/TGF-beta-1 | ||||
| Endotoxin level | Please contact the lab for this information. | ||||
| Purity | >95% purity as determined by SDS-PAGE. | ||||
| Purification | Protein A/G purified from cell culture supernatant. | ||||
| Accession | P54831 | ||||
| Form | Liquid | ||||
| Storage buffer | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
||||
| Product Usage Information |
| ||||
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. | ||||
| Alternate Names | ZTS00521426, ZTS-00521426, ZTS00521426, 2473240-98-9 | ||||
| Background | Transforming growth factor beta-1 proprotein (TGFB1) is a ~44 kDa protein. Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively. | ||||
| Note | For research use only. Not suitable for clinical or therapeutic use. |

SDS-PAGE for Research Grade Cirevetmab.
Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com


+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский